NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes immunotherapy company, has been invited to present at the French Biotech Tour Conference, Wednesday, March 17 at the UCSF-Mission Bay Conference in San Francisco. Some notable international healthcare companies slated to attend include:
